Evidence map›Paper›PMID 42811124›Full record

ArticleWorld journal of urology2026

Development and internal validation of a preoperative score for predicting postoperative residual stone after mini-percutaneous nephrolithotomy.

Hüseyin Mert Durak, Adem Sancı, Emre Hepşen, Anar Aghayev, Alper Gök

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hüseyin Mert DurakDepartment of Urology, Ankara Etlik City Hospital, Ankara, Turkey. hmertdurak@gmail.com.ORCID http://orcid.org/0000-0003-4839-9981
Adem SancıDepartment of Urology, Ankara Etlik City Hospital, Ankara, Turkey.
Emre HepşenDepartment of Urology, Ankara Etlik City Hospital, Ankara, Turkey.
Anar AghayevDepartment of Urology, Isparta Meddem Hospital, Isparta, Türkiye, Turkey.
Alper GökDepartment of Urology, Ankara Etlik City Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop and internally validate a simple preoperative scoring system for predicting postoperative residual stone after mini-percutaneous nephrolithotomy (mini-PCNL).

methodsThis retrospective single-center study included 217 adult patients who underwent pure mini-PCNL between May 2024 and December 2025. Postoperative stone clearance was assessed exclusively by non-contrast computed tomography. Clinically significant residual stone was defined as any residual fragment larger than 4 mm. Patients with no residual fragment or residual fragments ≤ 4 mm were classified as having no clinically significant residual stone. Univariable and multivariable logistic regression analyses were performed to identify independent preoperative predictors of residual stone. Based on the final multivariable model, a simplified preoperative scoring system, the Mini-PCNL Residual Stone Score, was constructed. Discriminative ability was evaluated using receiver operating characteristic (ROC) analysis, and internal validation was performed with bootstrap resampling. The score was also compared with the S.T.O.N.E. nephrolithometry score and Guy's Stone Score in the same cohort.

resultsOverall, 178 patients (82.0%) had no clinically significant residual stone, whereas 39 patients (18.0%) had clinically significant residual stone. Higher body mass index, greater stone number, larger stone volume, higher stone density, and the presence of a lower pole stone were independently associated with postoperative clinically significant residual stone. The Mini-PCNL Residual Stone Score ranged from 0 to 19 points and showed strong discrimination, with an AUC of 0.961. The optimal cut-off value was ≥ 10 points, corresponding to a sensitivity of 87.2% and a specificity of 93.3%. Internal validation demonstrated stable performance, with a bootstrap 95% confidence interval for the AUC of 0.929-0.986. After bootstrap correction for optimism, the optimism-corrected AUC was 0.954. In an exploratory comparison, the Mini-PCNL Residual Stone Score showed numerically higher discrimination than the S.T.O.N.E. nephrolithometry score and Guy's Stone Score.

conclusionThe Mini-PCNL Residual Stone Score is a simple and clinically applicable preoperative tool for estimating clinically significant residual stone risk after mini-PCNL. Because it is based entirely on routinely available preoperative variables, it may support individualized counseling and treatment planning. External validation in independent multicenter cohorts is needed before broader clinical use.

Indexed as

Kidney CalculiNephrolithotomy, PercutaneousAdultFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesNephrolithotomy,Percutaneous; Mini-percutaneous nephrolithotomy; Kidney calculi; Risk assessment; ROC Curve; Tomography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.